EirGen Pharma

EirGen Pharma

  • About Us
    • Company Overview
    • Our Approach
    • Our Team
    • Approvals
    • Global Operations
    • Quality
    • About OPKO
    • Community
  • R&D
    • Capabilities
    • How we do things
    • Partner with EirGen R&D
  • Commercial
    • Capabilities
    • How We Do Things
    • Partner with EirGen
  • News
  • Join Us
    • Work with Us
    • Job Opportunities
    • World Class Location
  • Contact Us

COMMERCIAL

  • All
  • COMMERCIAL
  • COMMUNITY
  • COMPANY UPDATES
  • News
  • R&D

EirGen Pharma Product Eir-102 Passes Bioequivalence Study in US

April 17, 2017
Read More

FDA Approval for EirGen Product EIR-087

March 23, 2017
Read More

EirGen Pharma successfully completes Pre-Approval Inspection with US FDA

March 3, 2017
Read More

OPKO Announces U.S. Launch of RAYALDEE™

November 23, 2016
Read More

EirGen Pharma Product EIR-050 Launches in Mexico

March 31, 2016
Read More

EirGen Pharma Product Eir-126 Passes Bioequivalence Study in US

February 29, 2016
Read More

EirGen Pharma Product EIR-116 receives first Regulatory Approval

February 26, 2016
Read More

ANDA Approval for EirGen Product EIR-060

February 11, 2016
Read More

EirGen Pharma Product EIR-101 Passes Bioequivalence Study

September 30, 2015
Read More

Posts navigation

Older Entries
Contact Us 
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
Connect With Us: 
  • Terms of Use
  • Privacy Policy